About Us

Science-first. Patient-focused. Built to last.

Inhibrx Biosciences was founded with a singular conviction: that the most precise biologics will deliver the most meaningful outcomes for patients with cancer and rare diseases.

Our Origin

Born from a landmark transaction

In January 2024, Inhibrx Biosciences was established as an independent company following the sale of INBRX-101 to Sanofi — a transaction that validated the power of our platform and provided the capital to pursue our next chapter.

Headquartered in La Jolla, California, we carry forward the scientific rigor and entrepreneurial spirit that defined our origins, now focused entirely on advancing our proprietary single-domain antibody platform across oncology and rare disease.

Founded
January 2024
Headquarters
La Jolla, California
Listed
NASDAQ: INBX
Focus
Oncology & Rare Disease

Mission

Translating biology into medicines that matter

We believe that the intersection of structural biology, protein engineering, and clinical insight is where the next generation of cancer medicines will be discovered. Our mission is to build that future — one precisely engineered molecule at a time.

What We Stand For

Principles that guide every decision

Scientific Rigor

Every decision is grounded in data. We pursue the hardest problems because the patients who need us most deserve nothing less.

Precision by Design

Our sdAb platform isn't a shortcut — it's a deliberate engineering choice that enables specificity, stability, and efficacy at the molecular level.

Patient Centricity

We develop therapeutics for oncology and rare diseases because these are the areas of greatest unmet need — and greatest opportunity to change lives.

Transparency

As a publicly traded company, we hold ourselves accountable to patients, researchers, and investors through open, honest communication.

Leadership

Experienced team. Shared purpose.

Our leadership team brings together decades of experience in drug development, structural biology, clinical operations, and business strategy — united by a commitment to advancing transformative medicines.

Where We Work

La Jolla, California

Nestled in one of the world's premier biotech ecosystems, our La Jolla headquarters places us at the center of a vibrant scientific community — with proximity to world-class research institutions, clinical networks, and talent.

La Jolla, California 92037
NASDAQ: INBX

La Jolla, California

La Jolla, California 92037

Ready to explore our science?

Discover the sdAb platform and our clinical programs.

Inhibrx Biosciences

A clinical-stage biopharmaceutical company developing novel biologic therapeutics for oncology and rare diseases through our proprietary sdAb platform.

NASDAQ: INBXLa Jolla, CA

© 2026 Inhibrx Biosciences, Inc. All rights reserved.

This website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause actual results to differ materially. Inhibrx Biosciences, Inc. undertakes no obligation to update any forward-looking statements.